Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kater AP"'
Autor:
Raa DGT; Department of Internal Medicine, Gelderse Vallei, Ede, the Netherlands., van der Straten L; Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, Rotterdam, The Netherlands., van Gelder M; Department of Hematology, Maastricht UMC, the Netherlands Maastricht., Kersting S; Department of Internal Medicine, HAGA hospital, Den Haag, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, the Netherlands., Mous R; Department of Hematology, UMC Utrecht, the Netherlands Utrecht., van der Straaten HM; Department of Internal Medicine, St Jansdal hospital, Harderwijk, the Netherlands., Nijziel MR; Department of Internal Medicine, Catharina hospital, Eindhoven, the Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate, Arnhem, the Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf hospital, Delft, the Netherlands.; Department of Hematology, Leiden Univerisity Medical Center, Leiden, the Netherlands., Visser HPJ; Department of Internal Medicine, Noordwest ziekenhuisgroep, Alkmaar, the Netherlands., van der Klift M; Department of Internal Medicine Amphia hospital, Breda, the Netherlands., de Heer K; Department of Internal Medicine, Flevo hospital, Almere, the Netherlands., Bellido M; Department of Hematology, Groningen University Medical Center, University of Groningen, Groningen, the Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Bruns AHW; Department of Hematology, UMC Utrecht, the Netherlands Utrecht., Raijmakers RAP; Department of Hematology, UMC Utrecht, the Netherlands Utrecht., Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Oct; Vol. 63 (10), pp. 2276-2289. Date of Electronic Publication: 2022 Jun 23.
Autor:
Amaador K; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Martens A; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands., de Boer R; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands., Rietveld J; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands., Heemskerk M; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Rutten CE; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands., Kersten MJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands., Vos J; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands., Tonino S; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Jun; Vol. 63 (6), pp. 1469-1473. Date of Electronic Publication: 2022 Feb 01.
Autor:
Svanberg R; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., Ostrowski SR; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.; Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Nasserinejad K; Erasmus MC Cancer Centre, HOVON Data Center, Clinical Trial Center, Rotterdam, Netherlands., Kersting S; Department of Hematology, HagaZiekenhuis, Den Haag, Netherlands., Dobber JA; Laboratory of Hematology, Amsterdam University Medical Centres, Amsterdam, Netherlands., Mattson M; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden., Tran HTT; Department of Hematology, Akershus University Hospital, Lorenskog, Norway., Levin MD; Department of Internal medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., Mous R; Department of Hematology, UMC Utrecht Cancer Center, Utrecht, Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Centres, Amsterdam, Netherlands., Niemann CU; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark.; Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (14), pp. 3422-3431. Date of Electronic Publication: 2020 Aug 31.
Autor:
Deng R; Genentech Inc, South San Francisco, CA, USA., Gibiansky L; QuantPharm, LLC, North Potomac, MD, USA., Lu T; Genentech Inc, South San Francisco, CA, USA., Li X; Genentech Inc, South San Francisco, CA, USA., Lu D; Genentech Inc, South San Francisco, CA, USA., Li C; Genentech Inc, South San Francisco, CA, USA., Girish S; Genentech Inc, South San Francisco, CA, USA., Wang J; Genentech Inc, South San Francisco, CA, USA., Boyer M; F. Hoffmann - La Roche Ltd, Welwyn Garden City, UK., Shankar N; Genentech Inc, South San Francisco, CA, USA., Humphrey K; F. Hoffmann - La Roche Ltd, Welwyn Garden City, UK., Freise KJ; AbbVie, North Chicago, IL, USA., Salem AH; AbbVie, North Chicago, IL, USA.; Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt., Seymour JF; Royal Melbourne Hospital, Peter MacCallum Cancer Centre, & University of Melbourne, Melbourne, Australia., Kater AP; Department of Hematology, Cancer Center Amsterdam, Hovon CLL Study Group, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Miles D; Genentech Inc, South San Francisco, CA, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Jan; Vol. 61 (1), pp. 56-65. Date of Electronic Publication: 2019 Sep 24.
Autor:
van der Straten L; a Department of Internal Medicine , Albert Schweitzer Hospital , Dordrecht , The Netherlands., Dinmohamed AG; b Department of Research , Netherlands Comprehensive Cancer Organisation (IKNL) , Utrecht , The Netherlands.; c Department of Public Health , Erasmus University Medical Centre , Rotterdam , The Netherlands.; d Department of Hematology , Erasmus MC Cancer Institute , Rotterdam , The Netherlands., Westerweel PE; a Department of Internal Medicine , Albert Schweitzer Hospital , Dordrecht , The Netherlands., Langerak AW; e Department of Immunology , Erasmus University Medical Centre , Rotterdam , The Netherlands., Riedl J; f Department of Clinical Chemistry , Result laboratories, Albert Schweitzer Hospital , Dordrecht , The Netherland., Doorduijn JK; d Department of Hematology , Erasmus MC Cancer Institute , Rotterdam , The Netherlands., Kater AP; g Department of Hematology , Academic Medical Centre , Amsterdam , the Netherlands., Levin MD; a Department of Internal Medicine , Albert Schweitzer Hospital , Dordrecht , The Netherlands.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2018 Nov; Vol. 59 (11), pp. 2757-2761. Date of Electronic Publication: 2018 Apr 04.
Autor:
De Back TR; a Department of Hematology and Lymphoma and Myeloma Center (LYMMCARE) , Academic Medical Center, University of Amsterdam , Amsterdam , The Netherlands., Kater AP; a Department of Hematology and Lymphoma and Myeloma Center (LYMMCARE) , Academic Medical Center, University of Amsterdam , Amsterdam , The Netherlands., Tonino SH; a Department of Hematology and Lymphoma and Myeloma Center (LYMMCARE) , Academic Medical Center, University of Amsterdam , Amsterdam , The Netherlands.
Publikováno v:
Expert review of hematology [Expert Rev Hematol] 2018 Aug; Vol. 11 (8), pp. 613-624. Date of Electronic Publication: 2018 Jul 14.
Autor:
Tonino SH; a Department of Hematology , Academic Medical Center , Amsterdam , The Netherlands.; b Lymphoma and Myeloma Center Amsterdam (LYMMCARE) , Amsterdam , The Netherlands., Mulkens CE; c Laboratory for Experimental Immunology, Academic Medical Center , Amsterdam , The Netherlands., van Laar J; c Laboratory for Experimental Immunology, Academic Medical Center , Amsterdam , The Netherlands., Derks IA; c Laboratory for Experimental Immunology, Academic Medical Center , Amsterdam , The Netherlands., Suo G; d Division of Hematology-Oncology, Department of Medicine , Moores Cancer Center, University of California , San Diego, La Jolla , CA , USA., Croon-de Boer F; e Department of Internal Medicine , Ikazia Hospital , Rotterdam , The Netherlands., van Oers MH; a Department of Hematology , Academic Medical Center , Amsterdam , The Netherlands.; b Lymphoma and Myeloma Center Amsterdam (LYMMCARE) , Amsterdam , The Netherlands., Eldering E; b Lymphoma and Myeloma Center Amsterdam (LYMMCARE) , Amsterdam , The Netherlands.; c Laboratory for Experimental Immunology, Academic Medical Center , Amsterdam , The Netherlands., Wang JY; d Division of Hematology-Oncology, Department of Medicine , Moores Cancer Center, University of California , San Diego, La Jolla , CA , USA., Kater AP; a Department of Hematology , Academic Medical Center , Amsterdam , The Netherlands.; b Lymphoma and Myeloma Center Amsterdam (LYMMCARE) , Amsterdam , The Netherlands.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2015; Vol. 56 (8), pp. 2439-47. Date of Electronic Publication: 2015 Jan 21.
Autor:
Lanasa MC; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. mark.lanasa@duke.edu, Kater AP, Shanafelt T, Fischer K
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2013 Aug; Vol. 54 (8), pp. 1815-6. Date of Electronic Publication: 2013 May 29.
Autor:
te Raa GD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Malcikova J, Pospisilova S, Trbusek M, Mraz M, Garff-Tavernier ML, Merle-Béral H, Lin K, Pettitt AR, Merkel O, Stankovic T, van Oers MH, Eldering E, Stilgenbauer S, Zenz T, Kater AP
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2013 Aug; Vol. 54 (8), pp. 1849-53. Date of Electronic Publication: 2013 Jun 24.
Autor:
te Raa GD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Tonino SH, Remmerswaal EB, van Houte AJ, Koene HR, van Oers MH, Kater AP
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2012 Nov; Vol. 53 (11), pp. 2321-5. Date of Electronic Publication: 2012 Aug 25.